Walleye Capital’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.2M Buy
51,500
+22,500
+78% +$1.01M 0.01% 1435
2026
Q1
$1.4M Sell
29,000
-120,700
-81% -$5.63M 0.01% 1770
2025
Q4
$7.25M Buy
149,700
+50,000
+50% +$2.48M 0.02% 866
2025
Q3
$4.71M Buy
99,700
+70,900
+246% +$3.42M 0.02% 954
2025
Q2
$1.39M Buy
28,800
+17,000
+144% +$869K 0.01% 1796
2025
Q1
$654K Sell
11,800
-35,000
-75% -$1.89M ﹤0.01% 2331
2024
Q4
$2.26M Sell
46,800
-3,100
-6% -$158K 0.01% 1674
2024
Q3
$2.88M Buy
49,900
+26,800
+116% +$1.45M 0.01% 1617
2024
Q2
$1.12M Buy
23,100
+20,200
+697% +$974K ﹤0.01% 2721
2024
Q1
$141K Sell
2,900
-72,400
-96% -$3.54M ﹤0.01% 4190
2023
Q4
$3.74M Sell
75,300
-8,700
-10% -$425K 0.01% 1294
2023
Q3
$4.51M Buy
84,000
+39,700
+90% +$2.12M 0.01% 1105
2023
Q2
$2.39M Buy
44,300
+42,700
+2,669% +$2.3M 0.01% 1210
2023
Q1
$87.1K Buy
+1,600
New +$77.8K ﹤0.01% 3007

Other funds holding SNY

Walleye Capital's SNY Position: Q2 2026 in Review

Walleye Capital increased its Sanofi (SNY) stake by 648% in Q2 2026, buying an estimated $1.28M and bringing the position to 33,051 shares worth $1.41M. The position accounts for 0.01% of the portfolio, ranked #1822.

Walleye Capital first reported a position in SNY in Q3 2018 and has held it in 12 quarters since. The position peaked at $9.38M in Q3 2023. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Walleye Capital held 33,051 shares of Sanofi worth $1.41M as of Q2 2026.
  • Walleye Capital bought 28,633 Sanofi shares in Q2 2026, an estimated $1.28M.
  • Sanofi made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1822 holding.
  • Walleye Capital first reported a position in Sanofi in Q3 2018 and has held it in 12 quarters since.
  • Walleye Capital's Sanofi position peaked at $9.38M in Q3 2023.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.